| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.33 | 0.05 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.19 | 0.3 |